CFDE Data Portal | Search LINC01915

	Label	Description
	LINC01915 Gene (Entity type)	ENSG00000265485 - long intergenic non-protein coding RNA 1915
	GSE217085 L-25 HeLa 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 10 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE130246 enzalutamide UM 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE178340 carfilzomib MM1.S 5 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147240 dasatinib 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147240 dasatinib 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233112 doxorubicin 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Prostate 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx

LINC01915

ENSG00000265485 - long intergenic non-protein coding RNA 1915

GSE217085 L-25 HeLa 1 v 0 human up

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 10 v 8 human dn

A Gene Set from LINCS

GSE130246 enzalutamide UM 2 v 0 human up

A Gene Set from LINCS

GSE226249 pirfenidone HL 2 v 1 human dn

A Gene Set from LINCS

GSE178340 carfilzomib MM1.S 5 v 9 human dn

A Gene Set from LINCS

GSE147240 dasatinib 3 v 6 human dn

A Gene Set from LINCS

GSE147240 dasatinib 3 v 7 human dn

A Gene Set from LINCS

GSE233112 doxorubicin 2 v 0 human dn

A Gene Set from LINCS

GTEx Prostate 20-29 vs 60-69 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.